Medicamen Organics Limited — Board Meeting, 13-03-2026: Outcome of Board Meeting

Medicamen Organics' board approved increasing authorized capital to ₹20 Cr. It will raise ~₹13.65 Cr via a preferential issue of equity shares & warrants at ₹35 each to strategic investors & promoters. Mr. Pankaj Tiwari's Executive Director appointment was also proposed, pending shareholder approval.